| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Change in numbers of shares and votes in Saniona AB (publ)
By: GlobenewsWire - 30 Jun 2020Back to overview list


June 30, 2020                                                           

During June, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to the exercising of warrants of series TO 1. As of June 30, 2020, the registered number of shares and votes in Saniona amounts to 30,383,316.

For more information, please contact
Rami Levin, President & CEO, Saniona, Mobile: +1 (781) 987 3144, Email:
Anita Milland, Interim CFO & Head of IR, Mobile +45-20163432, Email:

This information is such information as Saniona AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 8:00 p.m. CET on June 30, 2020.

About Saniona

Saniona is a rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system. The company has four programs in clinical development. Saniona intends to develop and commercialize treatments for rare disease indications such as Prader-Willi syndrome and hypothalamic obesity on its own. The research is focused on ion channels and the company has a broad portfolio of research programs. Saniona also has out-licensing agreements with Boehringer Ingelheim GmbH, Productos Medix, S.A de S.V and Cadent Therapeutics. Saniona is based in Copenhagen, Denmark, and in Boston, US. The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at


Copyright 2020 GlobenewsWire Back to overview list
to the top ↑